Dr. Rodriguez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Miami Health System
1475 NW 12th Ave
Miami, FL 33136Phone+1 305-243-3636
Summary
- Dr. Valentina Rodriguez is an endocrinologist in Miami, FL and is affiliated with multiple hospitals in the area, including Jackson Health System and Sylvester Comprehensive Cancer Center/University of Miami Hospitals and Clinic. She received her medical degree from University of Miami Miller School of Medicine and has been in practice 6 years. She also speaks multiple languages, including Spanish, French, and Italian. She specializes in parathyroid and thyroid and is experienced in neuroendocrine and pituitary disease, thyroid cancer, diabetic complications, pituitary disease, and adrenal disease.
Education & Training
- NYU Grossman School of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2016
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 2011 - 2014
- University of Miami Leonard M. Miller School of MedicineClass of 2011
Certifications & Licensure
- FL State Medical License 2018 - 2025
- NY State Medical License 2016 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Excellence in Teaching Award University of Miami- J. Maxwell McKenzie Endocrinology, Diabetes, &Metabolism Fellowship, 2019-2020
- Golden Key Honor Society University of Miami
- Honors in Medicine, Combined BS/MD 7 year program University of Miami, 2004-2011
Publications & Presentations
PubMed
- 14 citationsTowards more specific treatment for diabetic dyslipidemia.Valentina Rodriguez, Jonathan D. Newman, Arthur Schwartzbard
Current Opinion in Lipidology. 2018-08-01 - 12 citationsCardiovascular disease leads to a new algorithm for diabetes treatment.Valentina Rodriguez, Matthew C. Weiss, Howard Weintraub, Ira J. Goldberg, Arthur Schwartzbard
Journal of Clinical Lipidology. 2017-09-01 - 1 citationsCorrelates of Positive Thyroid Peroxidase Antibodies Among Firefighters: A Cross-Sectional-Study.Kemi Ogunsina, Tulay Koru-Sengul, Valentina Rodriguez, Alberto J Caban-Martinez, Natasha Schaefer-Solle
Journal of the Endocrine Society. 2022-10-01
Journal Articles
- Ischemic Monomelic Neuropathy: A Disguised Diabetic NeuropathyRodriguez V, Shah D, Grover V, Mandel S, Fox D, Bhatia N., Journal of Practical Neurology, 5/2013
Abstracts/Posters
- Somatostatin Analogue: An Effective Treatment for Pseudoglucagonoma SyndromeFranco Vallejo Garcia, MD, Valentina Rodriguez, MD., Endocrine Society, New Orleans, Louisiana, 3/24/2019
- Ovarian Hyperthecosis: An Important Differential in the Post-Menopausal Woman with HyperandrogenismRodriguez V, Hodak S., Endocrine Reviews, Boston, Massachusetts
- Timing is Everything: Studying Insulin Administration in the Inpatient SettingRodriguez V, Levin B, Mermelstein J, Yehuda M, Graham RE, J Gen Intern Med, 4/29/2014
- Join now to see all
Press Mentions
- Your Weight Gain Might Have Nothing to Do with Your DietJanuary 28th, 2019
- 11 Thyroid Symptoms in Women That Could Point to A Serious ProblemApril 6th, 2018
- A Rare Complication of Diabetes: Diabetic MyonecrosisMarch 29th, 2018
- Join now to see all
Committees
- Representative, Program Evaluation Committee 2014 - 2018
Research History
- Principal InvestigatorStudy EFC148383: A 52 wk Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy & Safety of Sotagliflozin compared to Glimepiride/Placebo Added to MF in Patients with T2DM who have Inadequate Glycemic control on MF monotx2017 - 2018
- SubinvestigatorAmgen Diabetes-Hypercholesterolemia/Mixed Dyslipidemia- Clinical Trial Program testing evolocumab for patients with elevated LDL-C and heart disease or at risk of heart disease.2016 - 2018
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish, French, Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: